SATTERTHWAITE LIVINGSTON 4

What Happened
Satterthwaite Livingston, a director of Chemours Co (CC), was granted 7,182 stock units on May 6, 2026. The Form 4 records the acquisition as an award (code A) at $0.00 per share (total cash value recorded $0). This is a director compensation grant rather than an open-market purchase or sale.

Key Details

• Transaction date: 2026-05-06; Form 4 filed: 2026-05-08 (appears timely — within the usual two-business-day window).
• Transaction type: A (award/grant); 7,182 units acquired at $0.00.
• Shares owned after transaction: Not specified in the filing.
• Footnotes:
  • F1 — These are stock units that convert one-for-one to Chemours common stock upon separation from Board service.
  • F2 — Includes deferred stock units and dividend equivalent units.
• No sale, option exercise, tax-withholding, or 10b5-1 plan noted in this filing.

Context
This is a routine director compensation grant (units that convert to shares when the director leaves the board) and not an open-market purchase or sale. Compensation awards signal pay structure for insiders and do not by themselves indicate the director is buying or selling shares for personal investment reasons.